Despite Biotricity's strong revenue growth, its P/S ratio is...

Despite Biotricity's strong revenue growth, its P/S ratio is lower than the industry, indicating shareholder doubt. The company's depressed P/S, despite higher forecasted growth, suggests investors expect future revenue volatility.